COPD 2015 is a conference that covers topics such as:
- Formulation developments and the manufacturing of dry powder inhalation products
- The advantages and disadvantages of combinational therapeutics
- Challenges in clinical trial designs and in drug development
- COPD and comorbidities
- ACOS Definition and characteristics of a grey-zone syndrome, excluded from current asthma and COPD trials
- "first in class" inhaled drugs for the treatment of COPD and cystic fibrosis
- Role of lymphoid follicles in COPD Novel delivery and formulation methods
- Recent advances made in COPD biomarkers
COPD 2015 brings together attendees involved or interested in:
- Respiratory Pharmacology
- Respiratory Physiology & Medicine
- Inflammatory Disease
- Medical Affairs
- Pulmonary Disease
- Respiratory, Inflammation and Autoimmunity
- Immunology
- Respiratory Therapeutics
- In-Vitro Biology
- Medical & Inhalation Devices
- Inflammation Discovery
- Biomarker
- Clinical Pharmacology
- Preclinical R&D
- Clinical Science
- Clinical Trials
- Global Data Informatics
- Discovery
- Brand Manager
- Business Development
- Respiratory Licensing & Regulation
- Commercial
